FDA-Inspected Site

LeMaitre Vascular, Inc.

11 FDA inspections are on record for LeMaitre Vascular, Inc. in North Brunswick, United States.

483· Form 483 issued

North Brunswick, United States · Last updated July 10, 2026

Overview

  • 11 FDA inspections are on record.
  • 6 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-04-16.

At a glance

Inspections

11

Form 483s

6

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
4 Mar 2025 – 16 Apr 2025Medical Devices & Rad Health483View 483 →
27 Mar 2023 – 13 Apr 2023Medical Devices & Rad Health483View 483 →
13 Feb 2018 – 16 Feb 2018Medical Devices & Rad HealthClean
13 Jan 2015 – 28 Jan 2015Medical Devices & Rad Health483View 483 →
15 Oct 2013 – 22 Oct 2013Medical Devices & Rad HealthClean
25 Jan 2013Not recordedClean
20 Dec 2010Not recorded483View 483 →
8 Mar 2010Not recordedWLView 483 →
24 Jan 2008Not recorded483On file
10 Jun 2003Not recordedClean
8 Dec 2000Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

16 Apr 2025
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Frank J Marciniak, Matthew W Kyle, Monica L Gutierrez

16 Apr 2025
21 CFR 820.184

DHR - not or inadequately maintained

Cited by Frank J Marciniak, Matthew W Kyle, Monica L Gutierrez

16 Apr 2025
21 CFR 820.25(b)

Training - Lack of or inadequate procedures

Cited by Frank J Marciniak, Matthew W Kyle, Monica L Gutierrez

16 Apr 2025
21 CFR 820.70(c)

Environmental control Lack of or inadequate procedures

Cited by Frank J Marciniak, Matthew W Kyle, Monica L Gutierrez

16 Apr 2025
21 CFR 820.70(e)

Contamination control, Lack of or inadequate procedures

Cited by Frank J Marciniak, Matthew W Kyle, Monica L Gutierrez

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.75(a)Cited across public-safe Form 483 observations5x
21 CFR 820.100(a)Cited across public-safe Form 483 observations3x
21 CFR 820.70(c)Cited across public-safe Form 483 observations3x
21 CFR 820.70(e)Cited across public-safe Form 483 observations3x
21 CFR 820.184Cited across public-safe Form 483 observations2x
21 CFR 820.25(b)Cited across public-safe Form 483 observations2x
21 CFR 820.75(b)Cited across public-safe Form 483 observations2x
21 CFR 820.75(c)Cited across public-safe Form 483 observations2x
21 CFR 820.100(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 820.150(a)Cited across public-safe Form 483 observations1x
21 CFR 820.181Cited across public-safe Form 483 observations1x
21 CFR 820.250(b)Cited across public-safe Form 483 observations1x
21 CFR 820.30(i)Cited across public-safe Form 483 observations1x
21 CFR 820.70(g)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.90(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind LeMaitre Vascular, Inc.'s 6 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat